Loading company…
Symbiosis develops ultra-fine bubbles and microbial technologies for intestinal flora.
Founded in 2017 and based in Osaka, Japan, Symbiosis develops ultra-fine bubble technology and products related to intestinal microorganisms. Its work includes NanoGAS® applications and research into intestinal flora transplantation. In August 2022, the company raised venture funding from Future Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in